• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[免疫复合物在慢性肝病中的作用及其治疗期间的动态变化]

[The role of immune complexes in chronic liver diseases and their dynamics during treatment].

作者信息

Iakhontova O I, Dudanova O P

出版信息

Ter Arkh. 1992;64(2):10-5.

PMID:1509358
Abstract

Chronic liver diseases are marked by a well-defined relationship between the intensity of the cytolytic syndrome and the level of circulating immune complexes (CIC). The highest damaging action on hepatocytes is produced by medium-sized CIC because of their penetrating and complement fixing effects. The level of thrombocytopenia and, to a less measure, of leukopenia also depends on the concentration and size of CIC in CAH and liver cirrhosis (LC), which may provide indirect evidence of the lytic action of CIC on hepatocytes, leading in turn to the impairment of microcirculation and aggravation of hepatocyte hypoxia. The data obtained attest to the role CIC of varying size play in the pathogenesis of CAH and LC. The changes in the properties of immune complexes induced by the derangement of cellular membranes also influence the course of immune responses, favouring an increase of antibody formation. As a result of an appreciable suppression of antibody and medium-sized CIC formation enhancing the cytolytic syndrome, the preference during glucocorticoid treatment should be given to the use of the medium doses of prednisolone which ensure less intensity and less duration of cytolysis as compared to the application of large drug doses.

摘要

慢性肝病的特征是细胞溶解综合征的强度与循环免疫复合物(CIC)水平之间存在明确的关系。中等大小的CIC对肝细胞产生的损伤作用最大,因为它们具有穿透和补体固定作用。血小板减少症的程度以及白细胞减少症程度较轻,也取决于慢性活动性肝炎(CAH)和肝硬化(LC)中CIC的浓度和大小,这可能间接证明了CIC对肝细胞的溶解作用,进而导致微循环受损和肝细胞缺氧加重。所获得的数据证明了不同大小的CIC在CAH和LC发病机制中的作用。细胞膜紊乱引起的免疫复合物性质变化也会影响免疫反应过程,有利于抗体形成增加。由于抗体和增强细胞溶解综合征的中等大小CIC形成受到明显抑制,糖皮质激素治疗期间应优先使用中等剂量的泼尼松龙,与大剂量药物应用相比,其可确保细胞溶解的强度和持续时间更低。

相似文献

1
[The role of immune complexes in chronic liver diseases and their dynamics during treatment].[免疫复合物在慢性肝病中的作用及其治疗期间的动态变化]
Ter Arkh. 1992;64(2):10-5.
2
Small albumin-immunoglobulin complexes in patients with liver disease.肝病患者体内的小白蛋白 - 免疫球蛋白复合物
Immunology. 1983 Apr;48(4):809-16.
3
Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
Med Interne. 1984 Jan-Mar;22(1):61-5.
4
[Liver-specific lipoprotein component level in circulating immune complexes in liver diseases].[肝脏疾病中循环免疫复合物里肝脏特异性脂蛋白成分水平]
Sov Med. 1989(11):14-6.
5
Circulating immune complexes in collagen diseases.胶原病中的循环免疫复合物。
Rom J Intern Med. 1991 Jul-Dec;29(3-4):145-9.
6
[Immunopathology of chronic liver diseases].[慢性肝病的免疫病理学]
Verh Dtsch Ges Pathol. 1995;79:186-97.
7
Immunological studies in HBV-related chronic liver diseases.乙型肝炎病毒相关慢性肝病的免疫学研究
Indian J Pathol Microbiol. 1990 Oct;33(4):351-4.
8
Immune complexes and human neoplasia. I.免疫复合物与人类肿瘤。I.
Biomed Pharmacother. 1983;37(3):119-25.
9
[The treatment with hepatoprotectors of patients with chronic liver diseases].[慢性肝病患者的保肝治疗]
Vrach Delo. 1990 May(5):18-20.
10
[Autoimmune liver diseases: the relation to other autoimmune pathology].[自身免疫性肝病:与其他自身免疫性病理的关系]
Ter Arkh. 1993;65(2):36-41.